NEW YORK, Nov 27 – Aclara BioSciences said that a trial judge has granted the company’s request to reduce a $52 million jury award in a microfluidics trade secret lawsuit with Caliper Technologies by $17 million .

“In addition, we intend to appeal the remaining $35 million and believe that we have strong grounds on which to base that appeal," Joseph Limber, president and CEO of Aclara said in a statement released Sunday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.